Research Technician III
M.S., Biochemistry, Mumbai University, India, 1988
Center for the Study of Systems Biology
310 Ferst Drive, Room 327
Atlanta GA, 30332, Mail Code: 0230
Tel: (404) 407-8976
Fax: (404) 385-7478
asha.rao@gatech.edu
Research Interests
- Anti-inflammatory research
- GnRH antagonists
- Cancer research
- Worked extensively with small animal models
- Experienced in Cell Culture Techniques
Publications
Papadopoulou MV, Ji M, Rao MK, Bloomer WD. Reductive metabolism of the nitroimidazole-based hypoxia-selective cytotoxin NLCQ-1 (NSC 709257). Oncol Res. 2003;14(1):21-9. doi: 10.3727/000000003108748577. PMID: 14552588.
Papadopoulou MV, Ji M, Rao MK, Bloomer WD. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as cytotoxin and radiosensitizer. Oncol Res. 1996;8(10-11):425-34. PMID: 9114435.
Papadopoulou MV, Ji M, Rao MK, Bloomer WD. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1): a novel DNA-affinic bioreductive agent as chemosensitizer. I. Oncol Res. 1997;9(5):249-57. PMID: 9306432.
Papadopoulou MV, Ji M, Rao MK, Bloomer WD. 4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamine. Oncol Res. 2001;12(8):325-33. doi: 10.3727/096504001108747774. PMID: 11589303.
Papadopoulou MV, Pouremad R, Rao MK, Ji M, Bloomer WD. In vitro evaluation of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-trifluoromethylquinoline hydrochloride (NLTQ-1), a new bioreductive agent as a hypoxia marker by 19F-magnetic resonance spectroscopy (19F-MRS). In Vivo. 2001 Sep-Oct;15(5):365-71. PMID: 11695231.